.
Non-DMARD Anti-Inflammatories
• Anti-inflammatory agents • Reduce heat, redness, swelling, improve function • They improve signs and symptoms but NOT disease modifying (do not change the outcome/progress of disease) • High risk of gastric ulcers with non-selective NSAIDs, if using for prolongued period of time, consider PPI (NOT H2 blockers, they improve symptoms, but do not decrease risk of ulcers) • 25% mouse, 75% human
Drug
• Initial Anti-TNF antibody did not help sepsis patients.
• Eventually TNF discovered as part of inflammatory cascade for RA • The group who developed the antibody were contacted, and tried on RA patients.
• Results were DRAMATIC • Tiredness + Fatigue gone in HOURS • Reduction in joint stiffness in DAYS • All patients responded, ESR decreased.
• BUT! After 8-26w relapsed due to few mechanisms (i.e. neutralizing antibodies) ▪ Found 3 ways to maintain response: 1. High dose 3-10mg/kg 2. Give with methotrexate 3. Humanize antibody (reduce mouse component, increase human components)
Anti-TNF Agents
• Used mostly in RA and spondyloarthropathies • Before Starting TNF Inhibitor:
• TB Surveillance (IGRA or skin test -IGRA more specific)
• HepB surveillance (can reactivate HepB)
• Ensure vaccines up to date (cannot administer live vaccines after, and may not mount a response to vaccines on TNF inhibitors -especially Rituximab).
• Cautions:
• 
